4/11
04:30 pm
nyxh
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
Medium
Report
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
3/29
04:30 pm
nyxh
Information on the total number of voting rights and shares
Medium
Report
Information on the total number of voting rights and shares
3/25
02:05 am
nyxh
Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation
Medium
Report
Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation
3/20
08:08 am
nyxh
Nyxoah S.A. (NASDAQ: NYXH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock, up previously from $18.00.
High
Report
Nyxoah S.A. (NASDAQ: NYXH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock, up previously from $18.00.
3/20
08:08 am
nyxh
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $27.00. They now have a "buy" rating on the stock.
High
Report
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $27.00. They now have a "buy" rating on the stock.
3/19
04:05 pm
nyxh
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
High
Report
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
3/18
03:05 pm
nyxh
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Oppenheimer Holdings Inc. from $17.00 to $20.00. They now have an "outperform" rating on the stock.
Neutral
Report
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Oppenheimer Holdings Inc. from $17.00 to $20.00. They now have an "outperform" rating on the stock.
3/7
10:02 am
nyxh
Nyxoah S.A. (NASDAQ:NYXH) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Nyxoah S.A. (NASDAQ:NYXH) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/6
09:37 am
nyxh
Nyxoah S.A. (NASDAQ: NYXH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Medium
Report
Nyxoah S.A. (NASDAQ: NYXH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
3/6
09:37 am
nyxh
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Piper Sandler from $15.00 to $20.00. They now have an "overweight" rating on the stock.
Medium
Report
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Piper Sandler from $15.00 to $20.00. They now have an "overweight" rating on the stock.
3/5
04:05 pm
nyxh
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
Medium
Report
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
3/5
09:11 am
nyxh
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Stifel Nicolaus from $10.00 to $20.00. They now have a "buy" rating on the stock.
Low
Report
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Stifel Nicolaus from $10.00 to $20.00. They now have a "buy" rating on the stock.
2/29
04:30 pm
nyxh
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Medium
Report
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
2/28
02:29 pm
nyxh
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at HC Wainwright from $15.00 to $18.00. They now have a "buy" rating on the stock.
Medium
Report
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at HC Wainwright from $15.00 to $18.00. They now have a "buy" rating on the stock.
2/15
04:30 pm
nyxh
Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024
Low
Report
Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024
2/9
09:28 am
nyxh
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Cantor Fitzgerald from $10.00 to $14.00. They now have an "overweight" rating on the stock.
Medium
Report
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Cantor Fitzgerald from $10.00 to $14.00. They now have an "overweight" rating on the stock.
2/1
03:30 pm
nyxh
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Piper Sandler from $10.00 to $15.00. They now have an "overweight" rating on the stock.
Low
Report
Nyxoah S.A. (NASDAQ: NYXH) had its price target raised by analysts at Piper Sandler from $10.00 to $15.00. They now have an "overweight" rating on the stock.